Clinical Trials

Phase 1/2 Active not recruiting

Advanced Malignant Solid Tumors

NCT06057922 2026-03-12

A Study YL201 in Patients With Selected Advanced Solid Tumors

990 enrolled

Advanced Solid Tumor

NCT07111546 2026-03-11

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

140 enrolled

Advanced Solid Tumour

NCT07069062 2026-03-09

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

261 enrolled

Solid Tumor

NCT07331155 2026-03-09

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

110 enrolled

Phase 1 Not yet recruiting

Advanced Solid Tumour

NCT07434609 2026-02-25

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

150 enrolled

Advanced Solid Tumor (Phase 1)

NCT06783647 2026-02-12

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

230 enrolled

Advanced Solid Tumour

NCT05620017 2026-02-09

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

182 enrolled

Phase 2 Not yet recruiting

Advanced Solid Tumors

NCT07390383 2026-02-09

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

110 enrolled

Advanced Solid Tumour

NCT06792552 2026-01-29

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

414 enrolled

Advanced Solid Tumors

NCT04284488 2026-01-08

Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors

Phase 1/2 Terminated

40 enrolled

Advanced Solid Tumor

NCT07326488 2026-01-08

A Study of MHB009C in Patients With Advanced Solid Tumors

Advanced Malignant Solid Tumor

NCT04175847 2026-01-07

A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1/2 Completed

198 enrolled

Solid Tumor

NCT06298058 2026-01-07

A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.

144 enrolled

Advanced Solid Tumor

NCT04617314 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1 Completed

67 enrolled

Solid Tumor

NCT05584800 2026-01-05

Study of ZGGS18 in Patients With Advanced Solid Tumors

222 enrolled

Advanced Solid Tumor

NCT06938880 2026-01-05

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

60 enrolled

Advanced Solid Tumor

NCT07252414 2026-01-05

GenSci143 in Participants With Advanced Solid Tumors

180 enrolled

Advanced Solid Tumors

NCT07251166 2025-12-24

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors

170 enrolled

Advanced Solid Tumors

NCT07298772 2025-12-23

A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors

198 enrolled

Advanced Solid Tumor

NCT07229586 2025-12-19

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors

100 enrolled

Solid Tumor

NCT07087197 2025-12-08

A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

90 enrolled

Metastatic Solid Tumors

NCT06428331 2025-12-05

A Study of SKB518 in Patients With Advanced Solid Tumors

150 enrolled

Advanced Solid Tumors

NCT06826040 2025-12-05

SKB445 for Injection in Solid Tumors

126 enrolled

Advanced Solid Tumors

NCT06840821 2025-12-02

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

156 enrolled

Advanced Solid Tumors

NCT07105215 2025-11-26

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

312 enrolled

Solid Tumors

NCT07083323 2025-11-25

A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors

262 enrolled

Advanced Solid Tumor

NCT06238401 2025-11-24

An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors

77 enrolled

Advanced Solid Tumors

NCT07126665 2025-11-18

A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors

116 enrolled

Advanced Malignant Solid Tumor

NCT05367635 2025-11-17

A Study of SKB315 in Patients With Advanced Solid Tumors

246 enrolled

Advanced Solid Tumors

NCT07231081 2025-11-17

Phase I Study of TX103 CAR-T Cells in Participants With Advanced Solid Tumors

85 enrolled

Solid Tumors

NCT07222969 2025-10-30

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

146 enrolled

Advanced Solid Tumors

NCT07192107 2025-09-25

A Study of MHB042C in Patients With Advanced Solid Tumors

Advanced Malignant Solid Tumor

NCT07192120 2025-09-25

A Study of MHB048C in Patients With Advanced Solid Tumors

GenitourinaryOther solid neoplasm

mCRPC (Metastatic Castration-resistant Prostate Cancer)

NCT06385678 2025-09-19

A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Phase 1/2 Active not recruiting

47 enrolled

Advanced KRAS G12D Mutant Solid Tumors

NCT06947291 2025-09-08

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

GastrointestinalOther solid neoplasm

350 enrolled

Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

NCT07136142 2025-08-22

A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

150 enrolled

Malignant Solid Tumor

NCT05109442 2025-08-20

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

Phase 1/2 Terminated

112 enrolled 28 charts

Advanced Solid Tumor

NCT06376136 2025-08-13

A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors

216 enrolled

Advanced Solid Tumors

NCT05109650 2025-08-12

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

Phase 1 Terminated

13 enrolled

Phase 1 Active not recruiting

Advanced Solid Tumour

NCT05906537 2025-08-07

SKB410 for Injection in Solid Tumors

54 enrolled

Advanced Solid Tumors

NCT07102004 2025-08-03

Study of MHB088C for Patients With Advanced Solid Malignant Tumors

515 enrolled

Phase 1 Active not recruiting

Advanced/Metastatic Solid Tumors

NCT05879627 2025-07-30

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

250 enrolled

Advanced Solid Tumors

NCT06543056 2025-07-30

A Study of ES014 in Subjects With Advanced Solid Tumors

15 enrolled

Advanced Solid Tumor

NCT06208410 2025-07-25

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

306 enrolled

Advanced Solid Tumors

NCT06992713 2025-07-23

A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors

36 enrolled

Advanced Solid Tumor

NCT06929663 2025-07-17

A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors

48 enrolled

Advanced Solid Tumors

NCT06132828 2025-07-03

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

216 enrolled

Solid Tumor

NCT07045454 2025-07-01

A Study of MHB118C Injection in Patients With Advanced Solid Tumors

Advanced Malignant Solid Tumor

NCT04975958 2025-06-22

Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

Phase 1 Completed

47 enrolled